scispace - formally typeset
L

Lily Yin Weckx

Researcher at Federal University of São Paulo

Publications -  64
Citations -  7479

Lily Yin Weckx is an academic researcher from Federal University of São Paulo. The author has contributed to research in topics: Vaccination & Vaccine efficacy. The author has an hindex of 17, co-authored 60 publications receiving 4311 citations.

Papers
More filters
Journal ArticleDOI

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.

Merryn Voysey, +81 more
- 09 Jan 2021 - 
TL;DR: ChAdOx1 nCoV-19 has an acceptable safety profile and has been found to be efficacious against symptomatic COVID-19 in this interim analysis of ongoing clinical trials.
Journal ArticleDOI

Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults

TL;DR: The HZ/su vaccine significantly reduced the risk of herpes zoster in adults who were 50 years of age or older and was similar to that in the other two age groups.
Journal ArticleDOI

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.

Merryn Voysey, +766 more
- 06 Mar 2021 - 
TL;DR: The ChAdOx1 nCoV-19 (AZD1222) vaccine has been approved for emergency use by the UK regulatory authority, Medicines and Healthcare products Regulatory Agency, with a regimen of two standard doses given with an interval of 4-12 weeks as discussed by the authors.